Incomplete diagnostic follow-up after a positive colorectal cancer screening test: A systematic review

Journal of Public Health (United Kingdom)

Volumn 40, Issue 1, 2018, Pages e46-e58

  Dalton, A R H ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

colonoscopy; colorectal cancer screening; faecal occult blood test; non attendance; systematic review

Indexed keywords

AFTERCARE; COLONOSCOPY; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; HUMAN; IMMUNOLOGICAL PROCEDURES; OCCULT BLOOD; PATIENT COMPLIANCE;

AFTERCARE; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; IMMUNOLOGIC TESTS; OCCULT BLOOD; TREATMENT ADHERENCE AND COMPLIANCE;

EID: 85031867091     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdw147     Document Type: Review

References (98)

1. Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016;23(4):179-85.
2. Bulliard J-L, Garcia M, Blom J et al. Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer. Eur J Cancer 2014;50(2):434-46.
3. The GLOBOCAN project. IARC 2012. http://globocan.iarc.fr/ Default.aspx (7 June 2016, date last accessed).
4. Callen JL, Westbrook JI, Georgiou A et al. Failure to follow-up test results for ambulatory patients: a systematic review. J Gen Intern Med 2012;27(10):1334-48.
5. Yabroff KR, Washington KS, Leader A et al. Is the promise of cancer-screening programs being compromised? Quality of followup care after abnormal screening results. Med Care Res Rev 2003;60 (3):294-331.
6. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103(6):1541-9.
7. (USPSTF) UPSTF Final recommendation statement: colorectal cancer, screening. In: (AHRQ) AfHRaQ, ed. Vol AHRQ Publication 08-05124-EF-3. Agency for Healthcare Research and Quality (AHRQ), Rockville USA, 2008.
8. Myers RE, Balshem AM, Wolf TA et al. Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation. Am J Public Health 1993;83(11):1620-2.
9. Chauvin P, Josselin JM, Heresbach D. The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening. Eur J Health Econ 2014;15(8):801-12.
10. von Wagner C, Baio G, Raine R et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011;40(3):712-8.
11. Guessous I, Dash C, Lapin P et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med 2010;50(1-2):3-10.
12. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151(4):264-9.
13. Alexander F, Weller D. Evaluation of the UK Colorectal Cancer Screening Pilot. London: Department of Health, 2003:21.
14. Shields HM, Weiner MS, Henry DR et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol 2001;96(1):196-203.
15. Steele RJ, Kostourou I, McClements P et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010;17(2):68-74.
16. Choi KS, Lee HY, Jun JK et al. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012;27(6): 1070-7.
17. Carlson CM, Kirby KA, Casadei MA et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? Arch Intern Med 2011;171(3):249-56.
18. Correia A, Rabeneck L, Baxter NN et al. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med 2015;76:115-22.
19. Denis B, Ruetsch M, Strentz P et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007;56(11):1579-84.
20. Dupont-Lucas C, Dejardin O, Dancourt V et al. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test. Dig Liver Dis 2011;43(9):714-20.
21. Ferrat E, Le Breton J, Veerabudun K et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer 2013;109(6):1437-44.
22. Fisher DA, Jeffreys A, Coffman CJ et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2006;15(6):1232-5.
23. Oluloro A. Timeliness of Follow-up to a Positive Fecal Immunochemical Test Among Community Health Center Patients. Portland, Oregon: Dept. of Public Health &Preventive Medicine, Oregon Health &Science University, 2015.
24. Oluloro A, Petrik AF, Turner A et al. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health 2016:1-7.
25. Steinmetz J, Spyckerelle Y, Gueguen R et al. Colorectal cancer screening in Health Examination Centers. Gastroenterol Clin Biol 2006;30(6-7):832-7.
26. Szczepura A, Johnson MRD, Orbell S, et al. Ethnicity: UK Colorectal Cancer Screening Pilot: Final Report 2003.
27. Welfare AIoHa. National Bowel Cancer Screening Program: Monitoring Report 2013-14. Canberra, Australia: AIHW;2015.
28. Mansouri D, McMillan DC, Grant Y et al. The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS One 2013;8(6):e66063.
29. Morris S, Baio G, Kendall E et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer 2012;107(5):765-71.
30. Moss SM, Campbell C, Melia J et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012;61(1): 101-7.
31. Etzioni DA, Yano EM, Rubenstein LV et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum 2006;49(7):1002-10.
32. Kearns B, Whyte S, Seaman HE et al. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm. Br J Cancer 2016;114(3):327-33.
33. Chong VH, Bakar S, Sia R et al. Colorectal cancer screening among government servants in Brunei Darussalam. Asian Pac J Cancer Prev 2013;14:7657-61.
34. Gellad ZF, Almirall D, Provenzale D et al. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Dig Dis Sci 2009;54(11):2497-2502.
35. Goulard H, Boussac-Zarebska M, Ancelle-Park R et al. French colorectal cancer screening pilot programme: results of the first round. J Med Screen 2008;15(3):143-8.
36. Logan RF, Patnick J, Nickerson C et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61(10):1439-46.
37. Paszat L, Rabeneck L, Kiefer L et al. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. Can J Gastroenterol 2007;21(6):379-82.
38. Turner B, Myers RE, Hyslop T et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med 2003;18(5):357-63.
39. Zorzi M, Mangone L, Anghinoni E et al. Screening for colorectal cancer in Italy: 2011-2012 survey. Epidemiol prev 2015;39(3 Suppl. 1):108.
40. Lo SH, Halloran S, Snowball J et al. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 2015;64(2):282-91.
41. Yang K-C, Liao C-S, Chiu Y-H et al. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen 2006;13 (Suppl. 1):8-13.
42. Rabeneck L, Tinmouth JM, Paszat LF et al. Ontario's ColonCancerCheck: results from Canada's first province-wide colorectal cancer screening program. Cancer Epidemiol Biomarkers Prev 2014;23(3):508-15.
43. Rao SK, Schilling TF, Sequist TD. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med 2009;24(3): 356-60.
44. Stock D, Rabeneck L, Baxter NN et al. Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's Colon Cancer Check program. Implement Sci 2015;10:35.
45. Blanks RG, Benson VS, Alison R et al. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women. Br J Cancer 2015; 112(9):1562-7.
46. Szczepura A, Price C, Gumber A. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian minority ethnic populations, corrected for differences in socio-demographic characteristics. BMC Public Health 2008;8(1):346.
47. Turrin A, Zorzi M, Giorgi Rossi P et al. Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey. Prev Med 2015;81:132-7.
48. Garman KS, Jeffreys A, Coffman C et al. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci 2006;332(4):159-63.
49. Yabroff KR, Klabunde CN, Myers R et al. Physician recommendations for follow-up of positive fecal occult blood tests. Med Care Res Rev 2005;62(1):79-110.
50. Koo JH, You MY, Liu K et al. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient. J Gastroenterol Hepatol 2012;27(2):390-6.
51. Partin MR, Burgess DJ, Burgess JF Jr et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomarkers Prev 2015;24(2):422-34.
52. Powell AA, Gravely AA, Ordin DL et al. Timely follow-up of positive fecal occult blood tests strategies associated with improvement. Am J Prev Med 2009;37(2):87-93.
53. McNamara D, Leen R, Seng-Lee C et al. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test. Eur J Gastroenterol Hepatol 2014;26(12):1415-21.
54. McNamara D, Qasim A, Lee N et al. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Ir J Med Sci 2011;180(2): 549-52.
55. Fasoli R, Faitini K, De Bastiani L et al. Effects of medical counselling on acceptance of colonoscopy in faecal occult blood testpositive subjects. Digestive and Liver Disease 2009;41:S115.
56. Baig N, Myers RE, Turner BJ et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 2003;98(9):2078-81.
57. Baig NA, Weinberg DS, Myers R et al. Inadequate follow-up of positive fecal occult blood test results: Survey of physician-reported reasons. Gastroenterology 2001;120(5):A66.
58. Jimbo M, Myers RE, Meyer B et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med 2009;7(1):11-6.
59. Plumb A, Ghanouni A, Lyratzopolous Y, et al. A168: Patient factors associated with non-completion of colonic testing after a positive Faecal occult blood test. NCRI Cancer Conference; 2015.
60. Laing SS, Bogart A, Chubak J et al. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev 2014;23(1):154-9.
61. Li CM, Shiu MN, Chia SL et al. Factors associated with referral compliance of abnormal immunochemical faecal occult blood test. J Med Screen 2007;14(4):186-90.
62. Cai S-R, Zhang S-Z, Zhu H-H et al. Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol 2009;15(20): 2531-6.
63. Zheng YF, Saito T, Takahashi M et al. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health 2006;6:272.
64. Ramos M, Llagostera M, Esteva M et al. Knowledge and attitudes of primary healthcare patients regarding population-based screening for colorectal cancer. BMC Cancer 2011;11(1):408.
65. Aubin-Auger I, Mercier A, Lebeau JP et al. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients. Fam Pract 2011;28(6):670-6.
66. O'Malley AS, Beaton E, Yabroff KR et al. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med 2004;39(1):56-63.
67. Miglioretti DL, Rutter CM, Bradford SC et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 2008;46(9 Suppl. 1): S91-96.
68. Chen ZJ, Kammer D, Bond JH et al. Evaluating follow-up of positive fecal occult blood test results: lessons learned. J Healthc Qual 2007;29(5):16-20, 34.
69. Larson MF, Ko CW, Dominitz JA. Effectiveness of a provider reminder on fecal occult blood test follow-up. Dig Dis Sci 2009;54 (9):1991-6.
70. Powell AA, Nugent S, Ordin DL et al. Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Med Care 2011;49(10):897-903.
71. Humphrey LL, Shannon J, Partin MR et al. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med 2011;26(7):691-7.
72. Murphy DR, Laxmisan A, Reis BA et al. Electronic health recordbased triggers to detect potential delays in cancer diagnosis. BMJ Qual Saf 2014;23(1):8-16.
73. Myers RE, Turner B, Weinberg D et al. Impact of a physicianoriented intervention on follow-up in colorectal cancer screening. Prev Med 2004;38(4):375-81.
74. Van Kleek E, Liu S, Conn LM et al. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests. J Healthc Qual 2010;32(6):62-9.
75. Van Kleek EJ, Hoadley A, Liu S et al. S1053 Effectiveness of fecal occult blood testing (FOBT) in a primary care clinic: quality improvement by direct GI referral for positive tests. Gastroenterology 2008;134(4):A-167.
76. Singh H, Wilson L, Petersen LA et al. Improving follow-up of abnormal cancer screens using electronic health records: trust but verify test result communication. BMC Med Inform Decis Mak 2009;9: 49.
77. Green BB, Anderson ML, Wang CY et al. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med 2014;27(6):789-95.
78. Rodger J, Steele RJ. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. J Med Screen 2008;15(2):105-7.
79. Zorzi M, Giorgi Rossi P, Cogo C et al. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes. Prev Med 2014;65:70-6.
80. Singh H, Kadiyala H, Bhagwath G et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009;104(4):942-52.
81. Genoff MC, Zaballa A, Gany F et al. Navigating language barriers: a systematic review of patient navigators' impact on cancer screening for limited English proficient patients. J Gen Intern Med 2016;31(4): 426-34.
82. Kobayashi LC, Wardle J, von Wagner C. Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing. Prev Med 2014;61:100-5.
83. Wardle J, McCaffery K, Nadel M et al. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med 2004;59(2):249-61.
84. Lo SH, Waller J, Vrinten C et al. Social cognitive mediators of sociodemographic differences in colorectal cancer screening uptake. Biomed Res Int 2015;2015:165074.
85. Jordan H, Roderick P, Martin D et al. Distance, rurality and the need for care: access to health services in South West England. Int J Health Geogr 2004;3(1):21.
86. Spring B, Moller AC, Coons MJ. Multiple health behaviours: overview and implications. J Public Health 2012;34(Suppl. 1):i3-10.
87. Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. Br Med J 2009;338:b2025.
88. Pruitt SL, Shim MJ, Mullen PD et al. Association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev 2009;18(10): 2579-99.
89. Weller DP, Campbell C. Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer 2009;101(Suppl. 2):S55-59.
90. Aubin-Auger I, Laouenan C, Le Bel J et al. Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial. Eur J Cancer Care (Engl) 2016;25(1): 18-26.
91. Baker DW, Brown T, Buchanan DR et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med 2014;174(8):1235-41.
92. McLachlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy in the screening context-A systematic review of the literature. Patient Educ Couns 2012;86(2): 137-46.
93. Partin MR, Gravely A, Gellad ZF et al. Factors associated with missed and cancelled colonoscopy appointments at veterans health administration facilities. Clin Gastroenterol Hepatol 2016;14(2):259-67.
94. Weller DP, Patnick J, McIntosh HM et al. Uptake in cancer screening programmes. Lancet Oncol 2009;10(7):693-9.
95. Verma M, Sarfaty M, Brooks D et al. Population-based programs for increasing colorectal cancer screening in the United States. CA Cancer J Clin 2015;65(6):497-510.
96. Kyte R. PMO-001 The role of the specialist screening practitioner within the bowel screening wales programme. Gut 2012;61(Suppl. 2):A73.
97. Sheridan SL, Halpern DJ, Viera AJ et al. Interventions for individuals with low health literacy: a systematic review. J Health Commun 2011;16(Suppl. 3):30-54.
98. Plumb AA, Ghanouni A, Rainbow S et al. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test. J Med Screen 2016. doi: 10.1177/0969141316645629.